You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma

Article metrics

Article menu

Download PDFPDF

XML
Short Report
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma

 

Online download statistics by month:

Online download statistics by month: January 2020 to November 2024

AbstractFullPdf
Jan 202020200
Feb 202086860
Mar 202087877
Apr 202010910922
May 202011211251
Jun 2020555526
Jul 2020505036
Aug 2020686664
Sep 20209594216
Oct 2020828162
Nov 202032933076
Dec 202010510559
Jan 202112012075
Feb 202110610650
Mar 202111911968
Apr 2021828355
May 2021999956
Jun 2021727249
Jul 2021696930
Aug 202110110058
Sep 2021949555
Oct 202117717792
Nov 202114814881
Dec 202114814972
Jan 202214014269
Feb 202211212283
Mar 202218019388
Apr 202220220872
May 202215816683
Jun 202216717373
Jul 202217017661
Aug 202212613580
Sep 202215216068
Oct 202219719954
Nov 202220520953
Dec 202213313352
Jan 202312512953
Feb 202314014557
Mar 202316616668
Apr 202314314759
May 202313213543
Jun 202311211340
Jul 202312412645
Aug 202312212348
Sep 202318218241
Oct 202328628738
Nov 202344244337
Dec 202321821842
Jan 2024798260
Feb 20249910134
Mar 202414715174
Apr 202412813173
May 202416116444
Jun 2024697139
Jul 202410210642
Aug 2024848335
Sep 2024747543
Oct 202411011562
Nov 202414414556
Total786479863329